J Schrader

Summary

Affiliation: Medizinische Klinik
Country: Germany

Publications

  1. doi request reprint [Prevention of vascular dementia. Evidence and practice]
    S Lüders
    Klinik fur Innere Medizin, St Josefs Hospital, Krankenhausstraße 13, Cloppenburg, Germany
    Internist (Berl) 53:223-31. 2012
  2. pmc Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study
    Walter Zidek
    Medizinische Klinik IV, Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
    Cardiovasc Diabetol 11:1. 2012
  3. pmc First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation
    Walter Zidek
    Medical Department IV, University Hospital Charite, Campus Benjamin Franklin, Berlin, Germany
    Cardiovasc Diabetol 7:22. 2008
  4. ncbi request reprint [Treatment of high blood pressure in acute stroke -- pro]
    J Schrader
    Medizinische Klinik, St Josefs Hospital Cloppenburg
    Dtsch Med Wochenschr 130:2662. 2005
  5. ncbi request reprint [Blood pressure lowering after stroke]
    J Schrader
    Medizinische Klinik, St Josefs Hospital Cloppenburg
    Dtsch Med Wochenschr 131:758-61. 2006
  6. ncbi request reprint [Old or new antihypertensives--which are better?]
    J Schrader
    St Josefs Hospital, Cloppenburg
    MMW Fortschr Med 147:36-7, 39-40. 2005
  7. ncbi request reprint [The significance of arterial hypertension for the development of dementia]
    J Schrader
    Medizinische Klinik, St Josefs Hospital, Cloppenburg
    MMW Fortschr Med 146:40-2. 2004
  8. ncbi request reprint [Cerebrovascular sequelae of hypertension]
    Joachim Schrader
    St Josefs Hospital, Cloppenburg, Germany
    Herz 28:707-16. 2003
  9. ncbi request reprint Inhibition of the renin-angiotensin system and the prevention of stroke
    Joachim Schrader
    St Josef s Hospital, Cloppenburg, Germany
    Am J Cardiovasc Drugs 7:25-37. 2007
  10. ncbi request reprint The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors
    Joachim Schrader
    Department of Internal Medicine, St Josefs Hospital Cloppenburg, Germany
    Stroke 34:1699-703. 2003

Detail Information

Publications32

  1. doi request reprint [Prevention of vascular dementia. Evidence and practice]
    S Lüders
    Klinik fur Innere Medizin, St Josefs Hospital, Krankenhausstraße 13, Cloppenburg, Germany
    Internist (Berl) 53:223-31. 2012
    ..Nevertheless, treatment of all other risk factors (e.g., diabetes mellitus, hyperlipidemia, atrial fibrillation) is important to reduce the onset of not only vascular but also Alzheimer dementia...
  2. pmc Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study
    Walter Zidek
    Medizinische Klinik IV, Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
    Cardiovasc Diabetol 11:1. 2012
    ..However, there are no real-world data available to illustrate the relevance for clinical practice...
  3. pmc First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation
    Walter Zidek
    Medical Department IV, University Hospital Charite, Campus Benjamin Franklin, Berlin, Germany
    Cardiovasc Diabetol 7:22. 2008
    ..Ramipril is an ACE inhibitor (ACEi), that has been shown to reduce cardiovascular events in high risk patients and post-hoc analyses of the HOPE trial have provided evidence for its beneficial action in the prevention of diabetes...
  4. ncbi request reprint [Treatment of high blood pressure in acute stroke -- pro]
    J Schrader
    Medizinische Klinik, St Josefs Hospital Cloppenburg
    Dtsch Med Wochenschr 130:2662. 2005
  5. ncbi request reprint [Blood pressure lowering after stroke]
    J Schrader
    Medizinische Klinik, St Josefs Hospital Cloppenburg
    Dtsch Med Wochenschr 131:758-61. 2006
  6. ncbi request reprint [Old or new antihypertensives--which are better?]
    J Schrader
    St Josefs Hospital, Cloppenburg
    MMW Fortschr Med 147:36-7, 39-40. 2005
    ..of the individual patient. In many cases, combination treatment should be considered from the very beginning...
  7. ncbi request reprint [The significance of arterial hypertension for the development of dementia]
    J Schrader
    Medizinische Klinik, St Josefs Hospital, Cloppenburg
    MMW Fortschr Med 146:40-2. 2004
    ..It is also possible that it can improve existing cognitive disorders in hypertensive patients. Further studies are needed to throw more light on this aspect...
  8. ncbi request reprint [Cerebrovascular sequelae of hypertension]
    Joachim Schrader
    St Josefs Hospital, Cloppenburg, Germany
    Herz 28:707-16. 2003
    ..Whether this is a drug-specific effect or due to lowering blood pressure per se is investigated at the moment. Antihypertensive treatment can reduce the incidence of vascular dementia and cognitive impairment...
  9. ncbi request reprint Inhibition of the renin-angiotensin system and the prevention of stroke
    Joachim Schrader
    St Josef s Hospital, Cloppenburg, Germany
    Am J Cardiovasc Drugs 7:25-37. 2007
    ..Therefore, ongoing trials will further define the exact role of inhibitors of the RAS and are urgently needed in secondary prevention, in acute stroke, and in the prevention of cognitive decline...
  10. ncbi request reprint The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors
    Joachim Schrader
    Department of Internal Medicine, St Josefs Hospital Cloppenburg, Germany
    Stroke 34:1699-703. 2003
    ..The study was also designed to provide an estimate of the number of cases required to perform a larger phase III efficacy study...
  11. ncbi request reprint BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan
    Joachim Schrader
    Department of Internal Medicine, St Josefs Hospital, Cloppenburg, Germany
    Clin Drug Investig 27:783-96. 2007
    ....
  12. doi request reprint [Drug treatment of pre-hypertension--pro]
    J Schrader
    Medizinische Klinik St Josefs Hospital, Krankenhausstrasse 13, 49661 Cloppenburg
    Dtsch Med Wochenschr 133:1304. 2008
  13. pmc [Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study)]
    Jurgen Schrader
    St Josefs Hospital, Cloppenburg
    Med Klin (Munich) 103:491-9. 2008
    ....
  14. doi request reprint [Stroke and hypertension]
    J Schrader
    Medizinische Klinik, St Josefs Hospital, Krankenhausstrasse 13, Cloppenburg, Germany
    Internist (Berl) 50:423-32. 2009
    ..The interrelation between vascular dementia and hypertension is by now also considered proven. An early start of antihypertensive treatment can prevent the development of dementia and impaired cognitive function...
  15. ncbi request reprint [Hypertension and stroke: new publications in 2005]
    J Schrader
    Medizinische Klinik, St Josefs Hospital, Cloppenburg
    MMW Fortschr Med 147:40-2, 44. 2005
    ..In studies investigators secondary prevention a sartan was found to prevent more cardiovascular events than nitrendipine...
  16. ncbi request reprint [Stress-associated hypertension in the work place: results of the STARLET project]
    S Lüders
    Medizinische Klinik, St Josefs Hospital, Cloppenburg
    Dtsch Med Wochenschr 131:2580-5. 2006
    ..To assess the influence of work stress and initial blood pressure on the prognosis of hypertension...
  17. ncbi request reprint Practice vs ambulatory blood pressure measurement under treatment with ramipril (PLUR Study): a randomised, prospective long-term study to evaluate the benefits of ABPM in patients on antihypertensive treatment
    J Schrader
    St Josefs Hospital, Ritterstr 17, D 49661 Cloppenburg, Germany
    J Hum Hypertens 14:435-40. 2000
    ....
  18. ncbi request reprint [Treating high blood pressure in acute stroke]
    J Schrader
    St Josefs Hospital, Cloppenburg
    MMW Fortschr Med 146:45-8. 2004
  19. ncbi request reprint [Lowering blood pressure--preventing 4 out of 10 strokes. Fully utilizing antihypertensive therapy]
    J Schrader
    Medizinische Klinik, St Josefs Hospital, Cloppenburg
    MMW Fortschr Med 142:22-5. 2000
    ..Antihypertensive therapy may apparently reduce significantly the risk of developing dementia. A further important aspect is non-dipping at sleep which is correlated with a worse prognosis of patients...
  20. pmc The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
    J Schrader
    St Josef Hospital, Cloppenburg, Germany
    Int J Clin Pract 63:217-25. 2009
    ..To demonstrate the benefit of the combination amlodipine/valsartan 5/160 mg over amlodipine 10 mg, in producing a lower incidence of peripheral oedema for a comparable mean sitting systolic blood pressure (MSSBP) reduction...
  21. ncbi request reprint Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice
    S Lüders
    St Josefs Hospital, Cloppenburg, Germany
    Int J Clin Pract 59:632-8. 2005
    ..A combination of HbA1c of > or =6%, a venous fasting glucose of > or =110 mg/dl, an age of > or =55 years, a systolic blood pressure of > or =140 mmHg and an enlarged waist size is highly predictive of impaired glucose tolerance...
  22. doi request reprint [Prevention of stroke: what is evidence based?]
    S Lüders
    St Josefs Hospital, Krankenhausstrasse 13, 49661, Cloppenburg, Deutschland
    Internist (Berl) 50:1337-44. 2009
    ..Treatment with platelet inhibitors plays an additional important role in secondary prevention. Patients with atrial fibrillation should receive an effective oral anticoagulatory therapy when there are certain risk factors...
  23. pmc Preventing stroke
    Joachim Schrader
    BMJ 324:687-8. 2002
  24. doi request reprint The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League
    Stephan Lüders
    Department of Internal Medicine, St Josefs Hospital, Cloppenburg, Germany
    J Hypertens 26:1487-96. 2008
    ....
  25. ncbi request reprint [In arterial hypertension: ACE inhibitors and combination therapy]
    Joachim Schrader
    Medizinischen Klinik St Josefs Hospital Krankenhausstrasse 13, 49661 Cloppenburg
    Pharm Unserer Zeit 32:46-52. 2003
  26. ncbi request reprint [Long-term follow-up of cardiovascular risk markers in patients with hypertension. Rationale, design, and baseline characteristics of the i-Search Plus Registry]
    Ulrich Tebbe
    Fachbereich Herz Kreislauf Lunge Niere, Klinikum Lippe GmbH, Detmold
    Med Klin (Munich) 102:824-32. 2007
    ..Blockade of the renin-angiotensin system (RAS) has been shown to reduce some of these risk markers in clinical trials, but validation of their time course and role in clinical practice is still pending...
  27. ncbi request reprint [The acute phase of stroke. Treating hypertension or not?]
    Joachim Schrader
    Medizinischen Klinik und Nephrologie St Josefs Hospital Krankenhausstrasse 13 D 49661 Cloppenburg
    MMW Fortschr Med 145:41-2. 2003
  28. ncbi request reprint [Antihypertensive drugs for dementia?]
    Joachim Schrader
    Medizinische Klinik, St Josefs Hospital, Krankenhausstrasse 13, D 49661 Cloppenburg
    MMW Fortschr Med 145:47-8. 2003
  29. ncbi request reprint Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES)
    Joachim Schrader
    Department of Internal Medicine, St Josefs Hospital, Cloppenburg, Germany
    Stroke 36:1218-26. 2005
    ..In hypertensive stroke patients, for the same level of blood pressure control, eprosartan will be more effective than nitrendipine in reducing cerebrovascular and cardiovascular morbidity and mortality...
  30. ncbi request reprint Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*
    Joachim Schrader
    Department of Internal, St Josefs Hospital Cloppenburg dInstitute for Hypertension and Cardiovascular Research, Cloppenburg, Germany
    J Hypertens 24:541-8. 2006
    ....
  31. ncbi request reprint [When blood pressure does not lower at night. Stroke risk is greatly elevated]
    Joachim Schrader
    Medizinischen Klinik und Nephrologie, St Josefs Hospital, Krankenhausstrasse 13, D 49661 Cloppenburg
    MMW Fortschr Med 144:55-6. 2002
  32. ncbi request reprint Low-grade albuminuria and cardiovascular risk : what is the evidence?
    Roland E Schmieder
    Medizinische Klinik 4, Nephrologie und Hypertensiologie, Universitatsklinikum Erlangen, Krankenhausstrasse 12, 91054, Erlangen, Germany
    Clin Res Cardiol 96:247-57. 2007
    ..MA is modifiable, and the inhibition of the renin-angiotensin system by ACE inhibitors and AT1 receptor antagonists has been shown to result in a lower incidence of cardiovascular events...